Related Experiment Video

Updated: Feb 22, 2026

Quantitative Autonomic Testing
11:40

Quantitative Autonomic Testing

Published on: July 19, 2011

58.8K

Real life practice of sweat testing in Europe

N Cirilli1, K W Southern2, R Buzzetti3

  • 1Cystic Fibrosis Centre, Mother-Child Department, United Hospitals, Ancona, Italy.

Insights

Sweat testing is crucial for diagnosing cystic fibrosis (CF), but European practices vary significantly and often deviate from established guidelines. This study highlights challenges in maintaining services and suggests improvements for CF diagnosis.

Area of Science:

  • Medical Diagnostics
  • Pulmonology
  • Genetics

Background:

  • Sweat testing is a cornerstone for diagnosing cystic fibrosis (CF), particularly after newborn bloodspot screening (NBS).
  • Maintaining effective sweat testing services faces challenges, including decreased referrals, younger patient populations, and outdated equipment.
  • The European Cystic Fibrosis Society (ECFS) Diagnostic Network Working Group surveyed current practices across Europe.

Purpose of the Study:

  • To define and analyze current sweat testing practices across European cystic fibrosis centers.
  • To identify variations in sweat testing procedures and adherence to existing guidelines.
  • To understand the challenges impacting the provision and reimbursement of sweat testing services.

Main Methods:

  • A comprehensive survey was distributed to 136 European respondents representing CF centers or laboratories.
  • Data collected included details on sweat collection, analysis, and interpretation of results.
  • Respondents were from diverse regions, with 65% operating in areas with established NBS programs.

Main Results:

  • Significant variability in sweat testing practices was observed across Europe, often inconsistent with evidence-based guidelines.
  • Collection of sweat from two sites, a recommendation in US guidelines, was rarely reported in European centers.
  • Discrepancies in cut-off values for positive and intermediate tests were noted, and cost/reimbursement emerged as a significant issue.

Conclusions:

  • Current European sweat testing practices exhibit considerable heterogeneity and deviations from guidelines.
  • Addressing practice variations, standardizing protocols, and resolving reimbursement issues are essential for sustaining high-quality sweat testing services.
  • This research will inform the development of improved best practice guidelines and resources to enhance CF diagnosis across Europe.